Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L K Webster

Showing results (41-50 of 52) with videos related to

Pageof 6
Sort By:
British Journal of Cancer|July 1, 1992
Reversal of multidrug resistance by surfactantsD M Woodcock, M E Linsenmeyer, G Chojnowski, et al.
Investigational New Drugs|November 11, 1999
A phase I and pharmacokinetic study of paclitaxel and epirubicin in advanced cancerD Rischin, L K Webster, M J Millward, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 1, 1983
Placental transfer and renal elimination of cimetidine in maternal and fetal sheepG W Mihaly, D B Jones, D J Morgan, et al.
Australian and New Zealand Journal of Medicine|June 1, 1996
Carboplatin dosing based on measurement of renal function--experience at the Peter MacCallum Cancer InstituteM J Millward, L K Webster, G C Toner, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1997
Radioenhancement by cisplatin with accelerated fractionated radiotherapy in a human tumour xenograftM A Joschko, L K Webster, J F Bishop, et al.
Journal of the National Cancer Institute|September 18, 1996
Cremophor pharmacokinetics in patients receiving 3-, 6-, and 24-hour infusions of paclitaxelD Rischin, L K Webster, M J Millward, et al.
Journal of Inorganic Biochemistry|January 8, 2000
Modifying the properties of platinum (IV) complexes in order to increase biological effectivenessT W Hambley, A R Battle, G B Deacon, et al.
Journal of Medicinal Chemistry|September 4, 1992
cis-bis(pyridine)platinum(II) organoamides with unexpected growth inhibition properties and antitumor activityL K Webster, G B Deacon, D P Buxton, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 31, 1998
Phase I trial of cremophor EL with bolus doxorubicinM J Millward, L K Webster, D Rischin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1997
Phase I trial of docetaxel and cisplatin in previously untreated patients with advanced non-small-cell lung cancerM J Millward, J Zalcberg, J F Bishop, et al.
Pageof 6

Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
British Journal of Cancer|July 1, 1992
Reversal of multidrug resistance by surfactantsD M Woodcock, M E Linsenmeyer, G Chojnowski, et al.
Investigational New Drugs|November 11, 1999
A phase I and pharmacokinetic study of paclitaxel and epirubicin in advanced cancerD Rischin, L K Webster, M J Millward, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 1, 1983
Placental transfer and renal elimination of cimetidine in maternal and fetal sheepG W Mihaly, D B Jones, D J Morgan, et al.
Australian and New Zealand Journal of Medicine|June 1, 1996
Carboplatin dosing based on measurement of renal function--experience at the Peter MacCallum Cancer InstituteM J Millward, L K Webster, G C Toner, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1997
Radioenhancement by cisplatin with accelerated fractionated radiotherapy in a human tumour xenograftM A Joschko, L K Webster, J F Bishop, et al.
Journal of the National Cancer Institute|September 18, 1996
Cremophor pharmacokinetics in patients receiving 3-, 6-, and 24-hour infusions of paclitaxelD Rischin, L K Webster, M J Millward, et al.
Journal of Inorganic Biochemistry|January 8, 2000
Modifying the properties of platinum (IV) complexes in order to increase biological effectivenessT W Hambley, A R Battle, G B Deacon, et al.
Journal of Medicinal Chemistry|September 4, 1992
cis-bis(pyridine)platinum(II) organoamides with unexpected growth inhibition properties and antitumor activityL K Webster, G B Deacon, D P Buxton, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 31, 1998
Phase I trial of cremophor EL with bolus doxorubicinM J Millward, L K Webster, D Rischin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1997
Phase I trial of docetaxel and cisplatin in previously untreated patients with advanced non-small-cell lung cancerM J Millward, J Zalcberg, J F Bishop, et al.
Pageof 6